The antimicrobial regenerative wound matrix market is estimated to secure a valuation of US$ 6.5 Billion in 2023 and is estimated to rise to US$ 9.2 Billion by 2033. The market is anticipated to grow at a CAGR of 3.5% during the forecast period. The factors accelerating the demand for antimicrobial regenerative wound matrices are as follows-
An increase in the growth of healthcare industries is anticipated to provide growth opportunities for the antimicrobial regenerative wound matrix market. Increasing demand for antimicrobial regenerative wound matrices from hospitals, medical centers, and speciality clinics is likely to provide the opportunity for market growth.
The increasing prevalence of chronic ulcers such as diabetes, foot ulcers, and sharp wounds is expected to provide an opportunity for antimicrobial regenerative wound matrix market growth. Also, the increased use of cost-effective regenerative wound matrix dressing products is expected to drive the expansion of the antimicrobial regenerative wound matrix market during the forecast period.
North America dominates the market for antimicrobial regenerative wound matrix and accounted for a larger revenue share in 2023. This dominance can be attributed to a well-developed advanced healthcare system and an increase in the number of surgical procedures.
The surging geriatric in Germany is projected to bolster Europe’s antimicrobial regenerative wound matrix market growth during the forecast period. Increased healthcare spending and rising demand for cutting-edge technology and expansion of the healthcare sector are expected to propel market growth in the region
Asia Pacific is expected to witness the highest CAGR during the forecast period owing to the increase in the geriatric population and changing lifestyles leading to chronic diseases in the region.
Some of the market participants in the antimicrobial regenerative wound matrix market include 3M, Turn Therapeutics, DSM Biomedical, H&R Healthcare limited, Harbor Medtech Inc, Aroa Biosurgery Ltd, Smith & Nephew Plc, Renovo Derm, BioLogiQ Inc, Integra LifeSciences, Johnson & Johnson, Gore Medical, Shire GmBH among others.
The market for antimicrobial regenerative wound matrices is highly fragmented with the presence of several small and large players. Furthermore, leading players are involved in collaborations, mergers, acquisitions, and product launches to strengthen their product portfolios.
For instance, turn therapeutics introduced XEAL Antimicrobial Dressing – it’s a single-use sterile gauze dressing impregnated with Hexagonal Formula. It allows additional wound management by combining the benefits of non-cytotoxic antimicrobial formula with the protective elements of non-adherent, porous gauze.
The market for antimicrobial regenerative wound matrix is expected to flourish during the forecast period owing to the increase in cases of surgical & traumatic wounds, venous leg ulcers, and pressure ulcers. With the increased demand for wound care products, start-ups are entering the antimicrobial regenerative wound matrix market with innovative products and services.
For instance, found in 2008 - Systagenix develops products for advanced wound therapeutics and regenerative medicines. The product range includes antimicrobial, manages odour, hydration promotes granulation, minimizes adherence, and manages exudate and compression.
| Data Point | Key statistics |
|---|---|
| Expected Market value in 2023 | US$ 6.5 Billion |
| Projected Market Value in 2033 | US$ 9.2 Billion |
| Growth Rate (2023 to 2033) | CAGR of 3.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Antimicrobial Regenerative Wound Matrix is a very important part of the wound care industry and global trade. Antimicrobial Regenerative Wound matrix is used to improve the regeneration of dermal and epidermal layers in both acute and acute wounds.
Antimicrobial Regenerative Wound Matrix is an extracellular matrix (ECM) based scaffold that has very high biocompatibility properties and biodegradability features for tissue regeneration. ECM is a complex of proteins, especially collagenous forming 3D structures and allowing the incorporation of growth factors.
Among the benefits of the Antimicrobial Regenerative Wound Matrix, is better able to allow cell formation by cells, enabling its effective integration with the surrounding tissues to be repaired and also to exert antimicrobial activity. The Antimicrobial Regenerative Wound Matrix can be used as an alternative to controlling surgical infections and reducing the use of antimicrobial agents
Acute and chronic wounds, e.g. burns and diabetic ulcers, respectively, place a significant burden on patients and healthcare systems. An increasing number of elderly people and people with diabetes will lead to an increase in chronic wounds such as sores on the feet fuelling the antimicrobial regenerative wound matrix market.
Such skin lesions are easily absorbed by the bacteria causing inflammation and this is why the healing process is challenging. Besides, the bacteria causing the infection prevent the recurrence of epithelialization and collagen synthesis. According to National Health Institute, the estimation of diabetic foot ulcers worldwide is around 6.5%.
The concept of moist wound healing, used in antimicrobial regenerative wound matrix, is now widely accepted and is associated with faster healing rates, reduced pain, better infection control, scar reduction, and lowering the cost of associated health care.
The use of skin-based ingredients offers an alternative treatment that demonstrates higher efficacy and, in some cases, a more cost-effective approach compared to traditional therapies.
Antimicrobial Regenerative Wound Matrix dressings are also widely used in wound dressing in the occurrence of road accident treatments and traumatic injuries.
An increasing prevalence worldwide of chronic ulcers such as diabetes, foot ulcers, and sharp wounds such as surgical and traumatic wounds is expected to increase in patients receiving wound care.
According to data published by the department of endocrinology of Nanjing university medical school in 2019 the prevalence of diabetic foot in North America was estimated to be 13% among diabetic patients.
Principal Consultant
The great economic and social impact of wounds in our society requires the allocation of a high level of attention and resources to understand the biological mechanisms that cause the severity of wounds.
According to a 2015 report, in Europe, as a result of ineffective treatment of such ulcers, 450,000 lower limbs each year have so far cost about € 2-2.5 billion. A USA figure indicates that 6.5 million patients are affected by chronic ulcers, whose annual medical expenses reach $ 25 billion. The US government spends $50 billion on wound care annually
Rise in sedentary lifestyle, chronic illnesses can lead to the development of chronic wounds and ulcers giving rise to the antimicrobial regenerative wound matrix market
It is estimated that a single diabetic ulcer carries an estimated cost of US $ 50,000 and the total chronic wounds cost the medical system more than the US $ 25 billion a year, with the number of affected patients growing each year from 6.5 million, given the increasing prevalence of diabetes and other chronic disease conditions that may affect wound healing.
An increase in the elderly and an increase in chronic diseases such as diabetes will fuel the antimicrobial regenerative wound matrix market. The formation of chronic wounds such as leg ulcers, foot ulcers, and pressure ulcers can increase with ageing, obesity, smoking, poor nutrition, and stress associated with diseases (e.g., AIDS) or drugs (e.g. chemotherapy or radiation therapy) are one of the few reasons giving Antimicrobial Regenerative Wound Matrix market rise in the future.
Antimicrobial Regenerative Wound Matrix is considered to lie on the higher side of the price scale due to the scarce scarcity of resources and high processing costs. The high cost can especially be a cause for concern in emerging markets.
Although the overall cost-effectiveness of Regenerative Wound Matrix products is lesser than traditional wound dressing. Lack of proper reimbursement for the products is one of the major restraining factors for the market, especially in developing countries. These restraints lead to the uptake of traditional wound dressing even in a few developed countries.
The development of a cost-effective Regenerative Wound Matrix dressing product can help in the expansion of the antimicrobial regenerative wound matrix market. Lack of proper information and knowledge about the Regenerative Wound Matrix products is one of the restraining factors for the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key players such as
are actively involved in offering Antimicrobial Regenerative Wound Matrix for different applications.
Key players involved in the Antimicrobial Regenerative Wound Matrix market are using strategies such as mergers and acquisitions, partnerships, and introducing new products to strengthen their position in the high-end wound dressing market.
In May 2019, 3M acquired Acelity, Inc. aiming to strengthen its wound management solutions and expand its customer base.Mergers and acquisitions have been majorly adopted and have shown great success to the key players in the expansion of Antimicrobial Regenerative Wound Matrix market share.
Rising healthcare industry in major countries in Asia will give a decent opportunity for the key players to expand the market share
The increase in chronic wounds due to diabetes and cancer and also increase in the elderly population have given rise to the antimicrobial regenerative wound matrix market. Also, there has been significant technological advancement in wound care management which has also become the main attraction for the antimicrobial regenerative wound matrix market.
An increase in the number of surgical procedures and acute wounds has also attracted manufacturers to invest in the antimicrobial regenerative wound matrix market. The proliferation of chronic diseases such as diabetes, cancer, and other autoimmune diseases, sedentary lifestyle, alcohol, and smoking has brought the need for Antimicrobial Regenerative Wound Matrix.
Natural polymers have been dominating the market with collagen and chitosan being the highest in demand due to their better ECM formation capability. Collagen and Silver-based products have also been great demanding compounds for the manufacturing of antimicrobial regenerative wound matrix products as silver has remained the best antimicrobial healing compound for decades.
Antimicrobial Regenerative Wound Matrix currently available in the market is usually made with hydrogels, films, sponges, and foam. As a new class of antimicrobial regenerative wound matrix, emerging ECM offers different benefits.
Antimicrobial Regenerative Wound Matrix tends to show higher altitudes thus allowing for adequate water and oxygen infiltration, as well as a higher exchange of nutrients and removal of debris.
They can provide excellent flexibility, thus being the best protection and protection against wounds. These benefits can boost the antimicrobial regenerative wound matrix market.
According to center for disease control and prevention the overall prevalence of surgical site infections caused by surgical wounds in 2018 were 2.8%. This will give a boost to the use of antimicrobial wound dressing products. Technological advancements in field of wound dressing will give rise to adoption of Antimicrobial Regenerative Wound Matrix.
The USA dominated the Antimicrobial Regenerative Wound Matrix market accounting for the largest revenue share. The reason involved the better healthcare services and medical infrastructure. Also better information about wound care management and its importance.
According to National Health Institute, North America has a prevalence of diabetic foot ulcers to be 13%. This ratio is higher than in Asia where it is around 5%. Europe stands second in terms of the Antimicrobial Regenerative Wound Matrix market due to rising awareness and information about the Regenerative Wound Matrix products. Europe is expected to grow at a significant CAGR due to the awareness about the products.
Asia-Pacific holds the emerging region for the growth of the market. Factors include cheaper availability of healthcare facilities and products. Also the rising increase of knowledge of wound management and rise in income has significantly increased the per capita healthcare spending.
Expansion of the healthcare industry in china, japan, and India will give a boost to the Antimicrobial Regenerative Wound Matrix market in Asia-Pacific region
The pandemic has greatly disrupted the Antimicrobial Regenerative Wound Matrix market. Due to coronavirus outbreaks, the flow of patients into the hospitals has been reduced which has led to the decline in the patients seeking treatments.
Also, the production industries have been largely obstructed due to lockdown causing an unprecedented technology and business model transformation. This disruption in the supply chain will hamper the production of the Antimicrobial Regenerative Wound Matrix products.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Wound 6.2. Material 7. Global Market Analysis and Forecast, By Wound 7.1. Acute 7.2. Chronic 8. Global Market Analysis and Forecast, By Material 8.1. Natural Polymer 8.1.1. Collagen 8.1.2. Cellulose 8.1.3. Chitosan 8.1.4. Pullulan 8.1.5. Starch 8.1.6. β-Glucan 8.1.7. Hyaluronic Acid 8.1.8. Alginate 8.2. Synthetic Polymer 8.2.1. Poly Ε-Caprolactone (PCL) 8.2.2. Poly Lactic Acid (PLA) 9. Global Market Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Europe 9.4. South Asia 9.5. East Asia 9.6. Oceania 9.7. Middle East & Africa 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Europe Sales Analysis and Forecast, by Key Segments and Countries 13. South Asia Sales Analysis and Forecast, by Key Segments and Countries 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries 15. Oceania Sales Analysis and Forecast, by Key Segments and Countries 16. Middle East & Africa Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Wound and Material for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. 3M 19.2. Turn Therapeutics 19.3. DSM Biomedical 19.4. H&R Healthcare Ltd 19.5. Harbor Medtech Inc. 19.6. Smith & Nephew Plc 19.7. Aroa Biosurgery Ltd. 19.8. RenovoDerm 19.9. Integra LifeSciences 19.10. BioLogiQ, Inc. 19.11. Johnson & Johnson 19.12. Gore Medical 19.13. Shire GmbH
Explore Healthcare Insights
View Reports
Antimicrobial Regenerative Wound Matrix Market
